BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kasper S. Phytopharmaceutical treatment of anxiety, depression, and dementia in the elderly: evidence from randomized, controlled clinical trials. Wien Med Wochenschr 2015;165:217-28. [PMID: 26092515 DOI: 10.1007/s10354-015-0360-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Sahiner M, Yilmaz AS, Gungor B, Sahiner N. A Review on Phyto-Therapeutic Approaches in Alzheimer's Disease. J Funct Biomater 2023;14. [PMID: 36662097 DOI: 10.3390/jfb14010050] [Reference Citation Analysis]
2 Seifritz E, Kasper S, Möller HJ, Volz HP, Müller WE, Eckert A, Hatzinger M. Effect of anxiolytic drug silexan on sleep - a narrative review. World J Biol Psychiatry 2022;23:493-500. [PMID: 36259937 DOI: 10.1080/15622975.2021.2013092] [Reference Citation Analysis]
3 Curpan AS, Luca AC, Ciobica A. Potential Novel Therapies for Neurodevelopmental Diseases Targeting Oxidative Stress. Oxid Med Cell Longev 2021;2021:6640206. [PMID: 34336109 DOI: 10.1155/2021/6640206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 von Känel R, Kasper S, Bondolfi G, Holsboer-Trachsler E, Hättenschwiler J, Hatzinger M, Imboden C, Heitlinger E, Seifritz E. Therapeutic effects of Silexan on somatic symptoms and physical health in patients with anxiety disorders: A meta-analysis. Brain Behav 2021;11:e01997. [PMID: 33638614 DOI: 10.1002/brb3.1997] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
5 Coppock RW, Dziwenka M. St John’s wort (Hypericum perforatum L). Nutraceuticals 2021. [DOI: 10.1016/b978-0-12-821038-3.00040-9] [Reference Citation Analysis]
6 Friedland K, Silani G, Schuwald A, Stockburger C, Koch E, Nöldner M, Müller WE. Neurotrophic Properties of Silexan, an Essential Oil from the Flowers of Lavender-Preclinical Evidence for Antidepressant-Like Properties. Pharmacopsychiatry 2021;54:37-46. [PMID: 33254260 DOI: 10.1055/a-1293-8585] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
7 Chopade AR, Somade PM, Somade PP, Mali SN. Identification of Anxiolytic Potential of Niranthin: In-vivo and Computational Investigations. Nat Prod Bioprospect 2021;11:223-33. [PMID: 33175328 DOI: 10.1007/s13659-020-00284-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Trkulja V, Barić H. Current Research on Complementary and Alternative Medicine (CAM) in the Treatment of Anxiety Disorders: An Evidence-Based Review. Adv Exp Med Biol 2020;1191:415-49. [PMID: 32002940 DOI: 10.1007/978-981-32-9705-0_22] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
9 Remde A, Teets R. Dietary Botanicals and Supplements. Geriatric Practice 2020. [DOI: 10.1007/978-3-030-19625-7_15] [Reference Citation Analysis]
10 Seifritz E, Schläfke S, Holsboer-trachsler E. Beneficial effects of Silexan on sleep are mediated by its anxiolytic effect. Journal of Psychiatric Research 2019;115:69-74. [DOI: 10.1016/j.jpsychires.2019.04.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
11 Tang SW, Tang WH, Leonard BE. Safety of traditional medicine and natural product supplements in psychiatry. Int Clin Psychopharmacol 2020;35:1-7. [PMID: 31361653 DOI: 10.1097/YIC.0000000000000279] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Lejri I, Agapouda A, Grimm A, Eckert A. Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence. Oxid Med Cell Longev 2019;2019:9695412. [PMID: 31214285 DOI: 10.1155/2019/9695412] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 14.0] [Reference Citation Analysis]
13 Urdaneta KE, Castillo MA, Montiel N, Semprún-Hernández N, Antonucci N, Siniscalco D. Autism Spectrum Disorders: Potential Neuro-Psychopharmacotherapeutic Plant-Based Drugs. Assay Drug Dev Technol 2018;16:433-44. [PMID: 30427697 DOI: 10.1089/adt.2018.848] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
14 Zhang H, Huang L, Zhong Y, Zhou Q, Wang H, Zheng G, Lin Y. Přehled systematických souhrnů studií: využití extraktu z Ginkgo biloba v léčbě mírného kognitivního poškození a demence. Neurol pro Praxi 2018;19:22-24. [DOI: 10.36290/neu.2018.145] [Reference Citation Analysis]
15 Rapp M, Burkart M, Kohlmann T, Bohlken J. Similar treatment outcomes with Ginkgo biloba extract EGb 761 and donepezil in Alzheimer's dementia in very old age: A retrospective observational study. Int J Clin Pharmacol Ther 2018;56:130-3. [PMID: 29319499 DOI: 10.5414/CP203103] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
16 Tang SW, Tang W, Leonard BE. Patients on psychotropic medications and herbal supplement combinations: clinical considerations. Int Clin Psychopharmacol 2017;32:63-71. [PMID: 27902536 DOI: 10.1097/YIC.0000000000000158] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
17 Tang SW, Tang WH, Leonard BE. Herbal medicine for psychiatric disorders: Psychopharmacology and neuroscience-based nomenclature. The World Journal of Biological Psychiatry 2019;20:586-604. [DOI: 10.1080/15622975.2017.1346279] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
18 Rahmati B, Kiasalari Z, Roghani M, Khalili M, Ansari F. Antidepressant and anxiolytic activity of Lavandula officinalis aerial parts hydroalcoholic extract in scopolamine-treated rats. Pharm Biol 2017;55:958-65. [PMID: 28166686 DOI: 10.1080/13880209.2017.1285320] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
19 Hyde AJ, May BH, Dong L, Feng M, Liu S, Guo X, Zhang AL, Lu C, Xue CC. Herbal medicine for management of the behavioural and psychological symptoms of dementia (BPSD): A systematic review and meta-analysis. J Psychopharmacol 2017;31:169-83. [PMID: 27899689 DOI: 10.1177/0269881116675515] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
20 Zhang HF, Huang LB, Zhong YB, Zhou QH, Wang HL, Zheng GQ, Lin Y. An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia. Front Aging Neurosci 2016;8:276. [PMID: 27999539 DOI: 10.3389/fnagi.2016.00276] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
21 Springer-Verlag Berlin Heidelberg. Pflanzen für die Psyche. CME 2016;13:44-45. [DOI: 10.1007/s11298-016-5920-y] [Reference Citation Analysis]
22 Naprienko MV, Esin RG, Mukhametova ER, Esin OR, Smekalkina LV. [Tanakan as a multimodal cytoprotective factor in general medicine]. Zh Nevrol Psikhiatr Im S S Korsakova 2015;115:146-51. [PMID: 27030838 DOI: 10.17116/jnevro2015115111146-151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]